Compare Medtronic PLC (MDT) vs Rigetti Computing Inc (RGTI) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Rigetti Computing (RGTI) trades at $14.25, up 0.99% on the day, with a bearish technical signal despite bullish oscillators. The company shows significant financial challenges with a net income margin of -2,253.59% and negative cash flow from operations of $58.54M in 2025. Recent earnings have consistently beaten expectations, and analyst consensus remains strongly bullish with an average price target of $32.67, representing 129% upside potential from current levels.

While RGTI faces substantial execution risks in the pre-commercial quantum computing space, its government contracts and technological positioning offer long-term potential. Investors should weigh the company's speculative nature against analyst optimism and the emerging quantum computing market opportunity, with careful attention to cash burn and commercialization timelines.